The store will not work correctly when cookies are disabled.
4-([1,1'-biphenyl]-4-ylsulfonyl)-2,7-dihydroxy-5-methylcyclohepta-2,4,6-trien-1-one
ID: ALA4514258
PubChem CID: 132051012
Max Phase: Preclinical
Molecular Formula: C20H16O5S
Molecular Weight: 368.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(O)c(=O)c(O)cc1S(=O)(=O)c1ccc(-c2ccccc2)cc1
Standard InChI: InChI=1S/C20H16O5S/c1-13-11-17(21)20(23)18(22)12-19(13)26(24,25)16-9-7-15(8-10-16)14-5-3-2-4-6-14/h2-12H,1H3,(H2,21,22,23)
Standard InChI Key: GYBAHBZEWJIVDC-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
33.6444 -5.3243 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.6485 -4.5071 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
32.9387 -4.9121 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.3006 -3.7695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8179 -3.1343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6412 -2.3336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9027 -1.9709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1610 -2.3140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9701 -3.1146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4783 -3.7637 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1134 -4.5011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5284 -1.7968 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.9122 -1.1496 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.2883 -1.8292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.4631 -4.5769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8062 -5.3156 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6198 -5.3840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0868 -4.7123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7344 -3.9703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9219 -3.9055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8978 -4.7765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2462 -5.5169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0599 -5.5842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5260 -4.9120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1727 -4.1704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3601 -4.1067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 2 1 0
5 4 1 0
6 5 2 0
7 6 1 0
8 7 1 0
8 9 2 0
9 10 1 0
10 4 2 0
10 11 1 0
8 12 1 0
7 13 2 0
6 14 1 0
2 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 368.41 | Molecular Weight (Monoisotopic): 368.0718 | AlogP: 3.27 | #Rotatable Bonds: 3 |
Polar Surface Area: 91.67 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.63 | CX Basic pKa: ┄ | CX LogP: 3.59 | CX LogD: 3.57 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.74 | Np Likeness Score: -0.56 |
References
1. Berkowitz AJ, Franson AD, Gazquez Cassals A, Donald KA, Yu AJ, Garimallaprabhakaran AK, Morrison LA, Murelli RP.. (2019) Importance of lipophilicity for potent anti-herpes simplex virus-1 activity of α-hydroxytropolones., 10 (7): [PMID:31391890] [10.1039/C9MD00225A] |